Navigation Links
Heparin Problems Reported in Germany
Date:3/6/2008

Adverse reactions similar to those in U.S., but product source is different, FDA says,,,,

THURSDAY, March 6 (HealthDay News) -- German health officials reported Thursday almost 100 cases of allergic reactions to heparin, a blood-thinning drug that has been blamed for hundreds of allergic reactions and at least four deaths in the United States.

But the German version of the drug is a different brand than the heparin supplied by Illinois-based Baxter Healthcare Corp. that has been linked to the allergic reactions in the United States, primarily among dialysis patients.

Following word of the German illnesses, the U.S. Food and Drug Administration said it was urging all U.S. suppliers of heparin to start using sophisticated screening tests to see if their products are free of a contaminant that is the leading suspect in the allergic reactions linked to Baxter's medication.

Baxter gets its main heparin ingredient, which is derived from pig intestines, from China. The heparin made by the German company, Rotexmedica, of Trittau, Germany, comes from a different supplier than the one used by Baxter. No deaths have been reported in Germany, officials said.

The adverse reactions seen in Germany occurred in a dialysis center and included severe allergic reactions and shock, U.S. health officials said.

"German authorities have identified a cluster of events in a dialysis center. They also have a cluster of similar reports from doctors," Dr. Janet Woodcock, acting director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, said during a Thursday afternoon teleconference.

"The heparin active ingredient in that [German] product is not obtained from the same source as the Baxter product," Woodcock added.

It's not yet known if the active ingredient in the German heparin came from China. And it's not known if the German heparin contains the same contaminant fo
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. FDA Finds Contaminant in Baxters Recalled Heparin Products
2. Baxter Recalls Rest of Heparin Products
3. Manufacturer Halts Production of Blood Thinner Heparin
4. Marijuana Use Among MS Patients Raises Risk for Cognitive, Mood Problems
5. Kidney Cancer Drug Linked to Higher Rate of Heart Problems
6. Geisinger study: PTSD a medical warning sign for long-term health problems
7. Children who have an active father figure have fewer psychological and behavioral problems
8. Learning Disabilities May Presage Later Language Problems
9. Hot Flashes Not Always to Blame for Sleep Problems in Menopausal Women, Reports the Harvard Womens Health Watch
10. Birth Problems Linked to Teenage Fathers
11. Children May Have Cholesterol Problems, Too
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... New York, New York (PRWEB) May 22, 2013 ... a metal-on-metal version of the DePuy Pinnacle Hip Replacement ... underway in Texas Federal Court, Bernstein Liebhard LLP reports. ... Court has directed DePuy Orthopaedics to produce monitoring reports ... government into the company’s medical device marketing practices. ...
(Date:5/22/2013)... Diversity Focus and Handicap This Productions announce ... promotes awareness that physical disabilities do not stop people ... be held Friday, June 14th at 7:30 p.m. at ... Handicap This! can be purchased at http://www.diversityfocus.org . ... to which their mind is handicap accessible. Mike ...
(Date:5/22/2013)... May 22, 2013 Twenty student-led startup ... year participating in an intensive startup accelerator designed to ... or services and create local jobs as part of ... year the Edson initiative offers approximately 20 student teams ... mentorship and training to launch their for-profit, more-than-profit or ...
(Date:5/22/2013)... University of Michigan study challenges previous research that ... , The study, a collaboration between researchers at ... looks deeper into the controversial argument over whether ... for pitchers of the same race. It found ... Jason Winfree, associate professor of sport management at ...
(Date:5/22/2013)... (HealthDay News) -- Over the next two decades, the ... expected to more than double, topping more than $180 ... main factor driving the increase: an aging population. The ... American Stroke Association, was published May 22 in the ... the health care system," Dr. Bruce Ovbiagele, chairman of ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 3Health News:Handicap This! Comes to Marion, Iowa 2Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 2Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 3Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 4Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 5Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 6Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 7Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 8Health News:ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort 9Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3
... will play host to 800 women from 55 countries ... from November 27. // ,The four-day international congress ... for the first time in South Asia. The earlier ... (1999) and Stockholm (2002)., ,Among its main objectives, ...
... flu, even as the government has given approval to clinical ... latest outbreaks of the deadly H5N1 strain of the flu ... of Yunnan and the northwestern region of Ningxia, the agriculture ... in Yunnan's Chuxiong district Thursday, and 230 died in Yinchuan, ...
... project, launched with the aim to combat AIDS will exploit ... around the world to aid research and identify drugs used ... ,The Internet-based initiative, called FightAIDS@Home, aims to enlist about 100,000 ... a secure website when they would otherwise be idle., ...
... from bird flu and other diseases, the US health ... to hand over// passenger and crew lists on demand ... Atlanta-based Centers for Disease Control and Prevention (CDC), the ... threats, has proposed the regulatory overhaul. The CDC said ...
... of breast-feeding is associated with reduction in risk of ... studies have already provided evidence for improved insulin sensitivity ... their counterparts. ,The study is the first of ... lactation and Type 2 diabetes. More than 1,57,003 parous ...
... - Conservative groups in the United States, who had ... the "morning-after" pill, are now having no such qualms ... vaccines manufactured by Merck & Co. and GlaxoSmithKline are ... from the market, but concerns had been voiced about ...
Cached Medicine News:Health News:Delhi To Host International Women’s Congress From Nov 2 2Health News:U.S. To Tighten Sick Passenger, Quarantine Rules 2Health News:Breastfeeding To Reduce Risk Of Type 2 Diabetes 2Health News:Religious groups overcome objections to cervical cancer vaccines 2
(Date:5/22/2013)... May 22, 2013  Modern Medical announced today ... Launched in November 2012 in a test phase, ... to stop the rising opioid abuse in the ... program designed to protect employees, physicians and employers ... necessary balance to provide pain relief for the ...
(Date:5/22/2013)... 2013 STEPh, Inc., a full service medical ... their web site ( http://www.stephreports.com ) dedicated ... About STEPh Reports STEPh Reports are comprehensive ... Each STEPh Report assesses the competitive landscape by individual ... company, and specific key issues.  STEPh Reports are written ...
(Date:5/22/2013)... 2013 MEDIFIRST SOLUTIONS, INC. (OTCQB: MFST) would ... some recent company developments. As Medifirst continues to expand ... with shareholders. Integrating social media into its investor relations ... will post updates on Twitter.  The Facebook homepage is ... Says CEO Bruce J. Schoengood ...
Breaking Medicine Technology:Modern Medical Introduces Opioid Abuse Solution to the Workers' Compensation Industry 2Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Medifirst Solutions, Inc. Announces Update To Shareholders 2
... Attend ROTH Fall Conference at Maui, Hawaii From September 1 -... -- CHENGDU, China, Aug. 30 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by ...
... 30 Phase 3 safety and efficacy data comparing tapentadol ... in patients with moderate to severe chronic osteoarthritis knee pain ... addition, this study compared oxycodone controlled release (CR) to placebo ... ER vs. Placebo The study demonstrated ...
Cached Medicine Technology:Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 2Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 3Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 4Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 5Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 6Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain 2Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain 3Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain 4Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain 5Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain 6Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain 7Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain 8Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain 9
... the ureter to be dilated immediately below ... base of the balloon allows fluoroscopic confirmation ... sterile in peel-open packages. Intended for one-time ... Straight Safety Wire Guide [.038 inch (0.97 ...
Used during the performance of balloon dilation procedures to inflate and deflate the balloon and measure the pressure within the balloon during the procedure. Supplied sterile in peel-open packages....
... Small 6.9 Fr Diameter with Two Large ... USA Series MICRO-6 Semi-Rigid Ureteroscope is the ... for diagnostic and therapeutic procedures. The ACMI ... time for procedures with minimal or no ...
Smooth, contoured visual obturator provides less traumatic insertion through the urethra and into the bladder....
Medicine Products: